Article
FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review)
20 Dec 2022
Abstract excerpt
Premature ovarian insufficiency (POI) is a common clinical disease of the reproductive system in which patients lose normal gonadal function prior to the age of 40. Common pathogenic factors include iatrogenic injury, genetics, inflammation, autoimmune, environmental and psychological factors. Patients with POI experience decreased estrogen secretion levels, ovulation disorder and infertility. POI appears...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
